Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK
ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
BMJ Open. 2020 Jul 21;10(7):e035632. doi: 10.1136/bmjopen-2019-035632.
Fever commonly leads to healthcare seeking and hospital admission in sub-Saharan Africa and Asia. There is only limited guidance for clinicians managing non-malarial fevers, which often results in inappropriate treatment for patients. Furthermore, there is little evidence for estimates of disease burden, or to guide empirical therapy, control measures, resource allocation, prioritisation of clinical diagnostics or antimicrobial stewardship. The Febrile Illness Evaluation in a Broad Range of Endemicities (FIEBRE) study seeks to address these information gaps.
FIEBRE investigates febrile illness in paediatric and adult outpatients and inpatients using standardised clinical, laboratory and social science protocols over a minimum 12-month period at five sites in sub-Saharan Africa and Southeastern and Southern Asia. Patients presenting with fever are enrolled and provide clinical data, pharyngeal swabs and a venous blood sample; selected participants also provide a urine sample. Laboratory assessments target infections that are treatable and/or preventable. Selected point-of-care tests, as well as blood and urine cultures and antimicrobial susceptibility testing, are performed on site. On day 28, patients provide a second venous blood sample for serology and information on clinical outcome. Further diagnostic assays are performed at international reference laboratories. Blood and pharyngeal samples from matched community controls enable calculation of AFs, and surveys of treatment seeking allow estimation of the incidence of common infections. Additional assays detect markers that may differentiate bacterial from non-bacterial causes of illness and/or prognosticate illness severity. Social science research on antimicrobial use will inform future recommendations for fever case management. Residual samples from participants are stored for future use.
Ethics approval was obtained from all relevant institutional and national committees; written informed consent is obtained from all participants or parents/guardians. Final results will be shared with participating communities, and in open-access journals and other scientific fora. Study documents are available online (https://doi.org/10.17037/PUBS.04652739).
在撒哈拉以南非洲和亚洲,发热通常会导致人们寻求医疗保健并住院治疗。对于管理非疟疾发热的临床医生来说,指导非常有限,这往往导致患者接受不适当的治疗。此外,对于疾病负担的估计,或者指导经验性治疗、控制措施、资源分配、临床诊断的优先排序或抗菌药物管理,证据也很少。发热性疾病在广泛流行地区的评估(FIEBRE)研究旨在解决这些信息空白。
FIEBRE 研究采用标准化的临床、实验室和社会科学方案,在撒哈拉以南非洲和东南亚及南亚的五个地点,对儿科和成年门诊和住院患者进行为期至少 12 个月的发热性疾病调查。出现发热的患者入组并提供临床数据、咽拭子和静脉血样;部分患者还提供尿样。实验室评估针对可治疗和/或可预防的感染。在现场进行选定的即时检验,以及血液和尿液培养和药敏试验。在第 28 天,患者提供第二份静脉血样进行血清学检测和临床结局信息。进一步的诊断检测在国际参考实验室进行。来自匹配的社区对照者的血液和咽拭子样本可计算出 AFs,并对寻求治疗的情况进行调查,以估计常见感染的发病率。其他检测可检测区分细菌和非细菌性病因的标志物,以及预测疾病严重程度的标志物。关于抗菌药物使用的社会科学研究将为未来的发热病例管理提供建议。从参与者身上采集的剩余样本将被储存以备将来使用。
所有相关机构和国家委员会均已获得伦理批准;所有参与者或其父母/监护人都获得了书面知情同意。最终结果将与参与社区共享,并在开放获取期刊和其他科学论坛上发布。研究文件可在网上查阅(https://doi.org/10.17037/PUBS.04652739)。